Sandu Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Sandu Pharmaceutical	Deccan Health Care	Vineet Laboratories
Operational Metrics
Financials
5 yr Average ROE	3.72 %	0.79 %	-20.75 %
5yr average Equity Multiplier	1.33	1.17	4.27
5yr Average Asset Turnover Ratio	1.23	0.47	1.52
5yr Avg Net Profit Margin	2.27 %	1.37 %	-4.28 %
Price to Book	0.88	0.34	2.53
P/E	23.66	25.78	0.0
5yr Avg Cash Conversion Cycle	48.49 Days	218.27 Days	179.8 Days
Inventory Days	74.6 Days	372.92 Days	114.74 Days
Days Receivable	26.14 Days	54.52 Days	109.14 Days
Days Payable	72.73 Days	94.94 Days	115.29 Days
5yr Average Interest Coverage Ratio	28.2	12.96	1.29
5yr Avg ROCE	5.33 %	2.08 %	-1.66 %
5yr Avg Operating Profit Margin	3.77 %	7.39 %	-0.62 %
5 yr average Debt to Equity	0.0	0.02	1.24
5yr CAGR Net Profit	0.39 %	24.36 %	n/a
5yr Average Return on Assets	2.79 %	0.68 %	-2.52 %
Shareholdings
Promoter Holding	42.91 %	18.42 %	15.89 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.56 %	-9.18 %	-20.07 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Sandu Pharmaceutical	Deccan Health Care	Vineet Laboratories
Product Wise Break-Up	Product Wise Break-Up Nutraceuticals 0 Others 100	Product Wise Break-Up Nutraceuticals 100.0	Product Wise Break-Up Nutraceuticals 0 Others 100